| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 108 | 6 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -124,377 | -126,279 |
| Cash and cash equivalents at beginning of period | 191,162 | - |
| Cash and cash equivalents at end of period | 66,785 | - |
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)